Currier v. Stryker Corporation et al
Filing
34
ORDER signed by Judge John A. Mendez on 03/26/12 ORDERING that the 28 Motion to Dismiss is DENIED. Defendants shall file their answer to the SAC within 20 days. (Benson, A.)
1
2
3
4
5
6
7
8
UNITED STATES DISTRICT COURT
9
EASTERN DISTRICT OF CALIFORNIA
10
11
12
TRAVIS J. CURRIER, an
individual,
Plaintiff,
13
v.
14
15
16
17
STRYKER CORPORATION; STRYKER
SALES CORPORATION; HOWMEDICA
ONSTEONICS CORP, dba STRYKER
ORTHOPAEDICS; and DOES 1-20,
Defendants.
18
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Case No. 2:11-CV-1203 JAM-EFB
ORDER DENYING DEFENDANTS’
MOTION TO DISMISS
This matter is before the Court on Defendants’ Stryker
19
20
Corporation (“Stryker”) and Howmedica Osteonics Corporation’s
21
(“Howmedica”) Motion to Dismiss (Doc. #28) Plaintiff Travis
22
Currier’s (“Plaintiff”) Second Amended Complaint (“SAC”), (Doc.
23
#26), for failure to state a claim pursuant to Federal Rule of
24
Civil Procedure 12(b)(6).
25
(Doc. #31).
26
is DENIED.1
Plaintiff opposes the motion to dismiss.
For the reasons set forth below, the motion to dismiss
27
1
28
This matter was determined to be suitable for decision without
oral argument. E.D. Cal. L.R. 230(g). Oral argument was scheduled
for February 22, 2012.
1
1
I.
2
FACTUAL ALLEGATIONS AND PROCEDURAL BACKGROUND
This action arises from a medical device that was surgically
3
implanted in Plaintiff’s leg.
Plaintiff alleges that a portion of
4
his left femur was removed due to sarcoma and replaced with femoral
5
endoprothesis (a femoral stem and joined pieces), in an operation
6
that took place in December 1994.
7
¶ 10.
8
Defendants’ product, and was dangerous and defective when it was
9
inserted into his femur.
Second Am. Compl.,
Plaintiff alleges that the femoral endoprothesis was
Second Am. Compl., ¶¶ 10-11. Plaintiff
10
was 15 at the time of the surgery.
11
¶ 10.
12
Plaintiff, his physician and his parents that the product was of
13
superior quality and would last for Plaintiff’s lifetime, the
14
product failed and broke in February 2010.
15
12.
16
surgery to replace the product that broke.
17
12.
18
Products Liability and Negligence.
19
damages, medical expenses and lost wages.
20
Second Am. Compl.,
The SAC alleges that despite Defendants’ representations to
Second Am. Compl., ¶
The product’s failure caused injury and necessitated further
Second Am. Compl., ¶
The SAC contains two claims against Defendants for Strict
Plaintiff seeks general
Defendants contend that the SAC does not correct the
21
deficiencies identified by the Court in its previous Order, (Doc.
22
#25), and that the SAC should be dismissed with prejudice.
23
Court’s Order granted in part and denied in part Defendants’ motion
24
to dismiss the First Amended Complaint.
25
found that Plaintiff had failed to state a claim for Strict
26
Liability, that Defendants had not properly moved to dismiss the
27
claim for Negligence, and that Plaintiff had failed to state a
28
claim for Breach of Warranty.
The
Specifically, the Court
Currier v. Stryker Corp., 2011 WL
2
1
4289501 (E.D. Cal. Oct. 13, 2011).
The Court granted leave to
2
amend the Strict Liability claim.
3
Liability claim and renewing the Negligence claim, Plaintiff argues
4
that he has sufficiently plead his claims in the SAC.
Having amended the Strict
5
6
II.
OPINION
7
A.
8
A party may move to dismiss an action for failure to state a
9
Legal Standard
claim upon which relief can be granted pursuant to Federal Rule of
10
Civil Procedure 12(b)(6).
11
court must accept the allegations in the complaint as true and draw
12
all reasonable inferences in favor of the plaintiff.
13
Rhodes, 416 U.S. 232, 236 (1974), overruled on other grounds by
14
Davis v. Scherer, 468 U.S. 183 (1984); Cruz v. Beto, 405 U.S. 319,
15
322 (1972).
16
are not entitled to the assumption of truth.
17
129 S. Ct. 1937, 1950 (2009), (citing Bell Atlantic Corp. v.
18
Twombly, 550 U.S. 544, 555 (2007)).
19
dismiss, a plaintiff needs to plead “enough facts to state a claim
20
to relief that is plausible on its face.”
21
570.
22
claim supportable by a cognizable legal theory.
23
Pacifica Police Department, 901 F.2d 696, 699 (9th Cir. 1990).
24
In considering a motion to dismiss, the
Scheuer v.
Assertions that are mere “legal conclusions,” however,
Ashcroft v. Iqbal,
To survive a motion to
Twombly, 550 U.S. at
Dismissal is appropriate where the plaintiff fails to state a
Balistreri v.
Upon granting a motion to dismiss for failure to state a
25
claim, the court has discretion to allow leave to amend the
26
complaint pursuant to Federal Rule of Civil Procedure 15(a).
27
“Dismissal with prejudice and without leave to amend is not
28
appropriate unless it is clear . . . that the complaint could not
3
1
be saved by amendment.”
2
316 F.3d 1048, 1052 (9th Cir. 2003).
3
B.
4
5
Eminence Capital, L.L.C. v. Aspeon, Inc.,
Motion
1.
Strict Products Liability
The first cause of action is a strict products liability claim
6
based on a manufacturing defect theory.
Plaintiff alleges that
7
Defendants’ product was designed so as not to break after
8
implantation in Plaintiff’s leg.
9
included the use of composite materials which were intended to last
Plaintiff alleges that the design
10
for the lifetime of the persons into which the femoral stem
11
products were implanted, and that a manufacturing, production and
12
testing process was also designed to ensure that the products were
13
of uniform composition and would not have weak areas where
14
composite material might break.
15
because the femoral stem product did break, the SAC alleges that
16
the product left Defendants’ possession with an inherent weakness
17
at the point of the break.
18
its design, the product had a defect when it was implanted which
19
made it likely to fail and break at the point where it did.
20
Am. Compl., ¶ 17.
21
sufficiently specific to allege a manufacturing defect claim.
Second Am. Compl., ¶ 16.
Second Am. Compl., ¶ 12.
However,
Contrary to
Second
Plaintiff argues that these allegations are
22
Defendants argue that the allegations merely state the
23
elements of a claim for manufacturing defect, and do not provide
24
sufficient factual support for a plausible manufacturing defect
25
claim.
26
describe, beyond using conclusory allegations, how the device at
27
issue was manufactured differently from other identical models.
28
Defendants argue that Plaintiff’s use of the terms “inherent
In particular, Defendants contend that Plaintiff fails to
4
1
weakness” to describe the defect is vague and implies an essential
2
problem with the design of the product, not a problem occurring
3
during manufacture.
4
California recognizes three theories of product liability:
5
design defect, manufacturing defect, and failure to warn.
6
v. Endocare, 2004 WL 5237598 at *3 (C.D. Cal. Nov. 8, 2004).
7
the manufacturing defect theory, generally a manufacturing or
8
production defect is readily identifiable because a defective
9
product is one that differs from the manufacturer’s intended result
10
or from other ostensibly identical units of the same product line.
11
Lucas v. City of Visalia, 726 F.Supp.2d 1149, 1154 (E. D. Cal.
12
2010) (internal citations omitted).
13
theory posits that a suitable design is in place, but that the
14
manufacturing process has in some way deviated from that design.
15
Id. at 1155.
16
the allegations may not simply track the general elements of strict
17
products liability without pertinent factual allegations.
18
plaintiff intending to allege a manufacturing defect “must
19
identify/ explain how the [product] either deviated from
20
[defendant’s] intended result/design or how the [product] deviated
21
from other seemingly identical [product] models.” Id.
22
Yalter
Under
The manufacturing defect
In order to state a claim for manufacturing defect,
Id.
A
Here, the SAC sufficiently states a claim for strict product
23
liability based on a theory of manufacturing defect.
24
Plaintiff does not offer an extensive explanation of the
25
manufacturing process and how such a process differed for
26
production of the femoral stem product at issue in this case, such
27
level of detail is not necessary at this stage of the pleadings.
28
Plaintiff has alleged that the product was properly designed and
5
While
1
used proper composite materials, but that this particular femoral
2
stem product differed from the intended design because it had a
3
manufacturing flaw that caused it to have a weak spot and
4
unexpectedly break.
5
product liability claim is DENIED.
6
2.
Accordingly, the motion to dismiss the strict
Negligence
7
The second claim is a negligence claim, alleging that
8
Defendants owed a duty of care to Plaintiff in the manufacture,
9
production and testing process so that the femoral stem products
10
that were subject to failure were not implanted into consumers,
11
including Plaintiff.
12
use due care for Plaintiff’s safety in their design, manufacturing,
13
production and/or testing process so that their femoral stem
14
product that was implanted into Plaintiff had a weak area where it
15
could break.
16
Defendants breached that duty by failing to
Second Am. Compl., ¶¶ 25, 26.
Defendants contend that the allegations in the negligence
17
claim are inadequate, as they do not differentiate between
18
Defendants and do not specify what duty of care is owed.
19
Defendants further argue that the SAC alleges the elements of a
20
negligence claim but does not plead any facts to support the claim.
21
22
23
24
25
26
A negligence claim under California law requires a plaintiff
to allege that
the defendant owed plaintiff a legal duty, breached
the duty, and that the breach was a proximate or legal
cause of plaintiff’s injury. In the context of a
products liability lawsuit, under a negligence theory,
a plaintiff must also prove that the defect in the
product was due to the negligence of the defendant.
27
In re Toyota Motor Corp. Unintended Acceleration, Marketing, Sales
28
Practices and Products Liability Litigation, 754 F.Supp.2d 1208,
6
1
2
1223 (C. D. Cal. 2010) (internal citations omitted).
Here, Plaintiff has alleged that Defendants owed a duty of
3
care to Plaintiff which was breached by Defendants’ negligence in
4
the design, manufacture, production or testing of the femoral stem
5
product, and Plaintiff was injured as a result when the implanted
6
product broke.
7
was the proximate cause of the Plaintiff’s injury, the product
8
reached Plaintiff without substantial change in the condition in
9
which it was sold by Defendants, and was used by Plaintiff and
10
11
Plaintiff has alleged that Defendants’ negligence
Plaintiff’s physician as anticipated by Defendants.
At this stage of the litigation, the Court must take the
12
allegations in the SAC as true, and Plaintiff has sufficiently
13
alleged a claim for negligence.
14
be able to prove that Defendants were negligent in the design,
15
manufacture or testing of the broken femoral stem product remains
16
to be seen, however, the allegations of the SAC are sufficient to
17
overcome a motion to dismiss.
18
the negligence claim is DENIED.
Whether Plaintiff will ultimately
Accordingly, the motion to dismiss
19
20
III. ORDER
21
For the reasons set forth above, the motion to dismiss is
22
DENIED. Defendants shall file their answer to the SAC within twenty
23
(20) days of this Order.
24
25
IT IS SO ORDERED.
Dated: March 26, 2012
____________________________
JOHN A. MENDEZ,
UNITED STATES DISTRICT JUDGE
26
27
28
7
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?